SCHEMBL1013966

SCHEMBL1013966

COC(=O)c1cc(Cl)ccc1NC(=O)COCC(=O)Nc1ccccc1Oc1ccccc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 9/20 0.60
HTT P42858 1/20 0.60
GAA P10253 3/20 0.56
KMT2A Q03164 2/20 0.56
CYP1A2 P05177 2/20 0.56
CYP3A4 P08684 2/20 0.56
CYP2C9 P11712 2/20 0.56
CYP2C19 P33261 2/20 0.56
POLB P06746 2/20 0.56
MEN1 O00255 1/20 0.56
LMNA P02545 2/20 0.56
ALDH1A1 P00352 4/20 0.53
NPSR1 Q6W5P4 3/20 0.53
THRB P10828 1/20 0.53
MAPK1 P28482 1/20 0.53
SMN1; SMN2 Q16637 1/20 0.53
TSHR P16473 1/20 0.53
MAPK10 P53779 1/20 0.53
HSD17B10 Q99714 1/20 0.53
TDP1 Q9NUW8 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1016077 0.90 POLB (0.60) L3MBTL1HTTGAAKMT2ACYP1A2
SCHEMBL1013843 0.88 L3MBTL1 (0.60) L3MBTL1HTTGAAKMT2ACYP1A2
SCHEMBL1015370 0.83 KDM4E (0.60) GAAKMT2ACYP1A2CYP3A4CYP2C9
SCHEMBL1794335 0.82 SMN1; SMN2 (0.69) GAAKMT2ACYP1A2CYP3A4CYP2C9
SCHEMBL1015136 0.80 SLC6A4 (0.51) GAAKMT2ACYP1A2CYP3A4CYP2C9
SCHEMBL1798978 0.80 SERPINE1 (0.53) L3MBTL1HTTGAAKMT2ACYP1A2
SCHEMBL1799240 0.80 MAPT (0.49) L3MBTL1GAAKMT2ACYP1A2CYP3A4
SCHEMBL1797516 0.79 ALDH1A1 (0.50) L3MBTL1GAAKMT2ACYP1A2CYP3A4
SCHEMBL7125633 0.79 ALDH1A1 (0.62) GAAKMT2ACYP1A2CYP3A4CYP2C9
SCHEMBL1794963 0.79 SERPINE1 (0.52) L3MBTL1HTTGAAKMT2ACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8415479-B2 Inhibitor of plasminogen activator inhibitor-1 RENASCIENCE CO., LTD. (JP) 2013-04-09 US disclosed
US-20110112140-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 RENASCIENCE CO., LTD. (JP) 2011-05-12 US disclosed
EP-2272822-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 Renascience CO., LTD. (JP) 2011-01-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110112140-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 SERPINE1, SERPINB1, SERPINC1 L3MBTL1 2670/4885HTT 1349/4885GAA 459/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.